Company page

Impedimed Limited

Impedimed Limited, trading under the ticker IPD, is a public company based in Australia with a market capitalization of approximately AUD 12.76 million. The company specializes in medical technology, focusing on the development of non-invasive devices for the assessment and management of lymphedema and other conditions. Impedimed aims to improve patient outcomes through innovative solutions in healthcare.